Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1022 (LINC01022, TCONS_00013107) is a non-coding RNA transcript longer than 200 nucleotides, located in genomic regions that do not overlap annotated protein-coding genes. LINC01022 belongs to the lincRNA subfamily, which distinguishes it from other lncRNAs by its position away from coding loci. LincRNAs are typically involved in diverse regulatory processes, such as chromatin remodeling, modulation of gene expression, and RNA stabilization, often acting in a highly tissue-specific manner. Some lincRNAs influence neighboring gene activity through changes in chromatin structure or recruitment of transcription factors, but most are not directly linked to drug action or considered classic therapeutic targets. The biological role of LINC01022 specifically is not well characterized, but it fits the general profile of lincRNAs as regulatory RNA molecules important for fine control of genetic programs and genome architecture.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1022 (LINC01022).